EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say

Reuters
Written By St. Paul Corner Drug (SPCD)

The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said on Monday.

Read the article here
St. Paul Corner Drug (SPCD)
Previous

DHS: 140,000 Minnesotans could lose health insurance under federal tax cut and spending package
Next

The only state without a Walgreens pharmacy